To ask the Scottish Government, further to the answer to the question S4W-28639 by Maureen Watt on 2 December 2015, how much recurring funding has been provided to NHS boards, and what proportion of this has been spent on new hepatitis C therapies. £9,625.6 million was given to NHS boards in 2015-16.